Research
An Inhaled RNA Drug Aims to Fix Cystic Fibrosis a Step Earlier
Modulator drugs fix the CFTR protein after the cell has built it wrong. ACT-101 is an inhaled RNA drug that aims to act before the protein exists at all — if it can be turned into a stable aerosol.